Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05625438 · ClinicalTrials.gov registry record · NA

Telerehabilitation Early After Stroke

A NA study of Cerebral Stroke, sponsored by TRCare.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05625438 is a NA study of Cerebral Stroke that is actively recruiting participants, run by TRCare. The registered enrollment target is 20 participants, below the 10,163-participant average among 6 other Cerebral Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05625438, a NA study of Cerebral Stroke, is actively recruiting participants, sponsored by TRCare.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to assess the safety and feasibility of providing extra doses of rehabilitation therapy for persons with a recent stroke. The therapy treatment targets to improve arm function by introducing telerehabilitation to the bedside of participants during the inpatient rehab admission period. Participants will use a newly developed functional training system (HandyMotion) to access therapy treatment program directly from their hospital room. HandyMotion is a sensor-based training system that can connect to the TV set in the hospital room, enabling patients to access their therapy training program to practice rehab-oriented games and exercises ad libitum, at any time of the day.

Conditions Studied

Interventions

  • DEVICE HandyMotion Treatment Program

Study Locations (1)

California

  • Providence St. Jude Medical Center - Fullerton

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-12-19
Est. Completion 2025-12
Phase NA

Sponsor

TRCare

2 total trials

What the Registry Record Tells You About NCT05625438

The ClinicalTrials.gov registry entry for NCT05625438 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,163-participant average among 6 other Cerebral Stroke trials with a reported enrollment target (100% lower). The listed sponsor is TRCare, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cerebral Stroke appearing as the primary indexed condition, and to 1 intervention - of which HandyMotion Treatment Program is the first listed.

NCT05625438 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05625438 about?

NCT05625438 is a clinical study titled "Telerehabilitation Early After Stroke". The goal of this clinical trial is to assess the safety and feasibility of providing extra doses of rehabilitation therapy for persons with a recent stroke. The therapy treatment targets to improve arm function by introducing telerehabilitation to the bedside of participants during the inpatient reh...

What is the current status of trial NCT05625438?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-12-19. Estimated completion is 2025-12.

What conditions does trial NCT05625438 study?

This clinical trial studies the following conditions: Cerebral Stroke.

What interventions are being tested in trial NCT05625438?

The interventions under investigation include: HandyMotion Treatment Program (DEVICE).

Who is sponsoring clinical trial NCT05625438?

This trial is sponsored by TRCare, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05625438 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.